- Home
- STRO vs FBYD Comparison
STRO vs FBYD Comparison
Compare STRO & FBYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- FBYD
- Stock Information
- Founded
- STRO 2003
- FBYD 2021
- Country
- STRO United States
- FBYD United States
- Employees
- STRO N/A
- FBYD N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- FBYD
- Sector
- STRO Health Care
- FBYD
- Exchange
- STRO Nasdaq
- FBYD Nasdaq
- Market Cap
- STRO 147.6M
- FBYD 152.9M
- IPO Year
- STRO 2018
- FBYD N/A
- Fundamental
- Price
- STRO $1.77
- FBYD $7.08
- Analyst Decision
- STRO Strong Buy
- FBYD
- Analyst Count
- STRO 7
- FBYD 0
- Target Price
- STRO $12.14
- FBYD N/A
- AVG Volume (30 Days)
- STRO 950.7K
- FBYD 48.9K
- Earning Date
- STRO 03-24-2025
- FBYD 03-07-2025
- Dividend Yield
- STRO N/A
- FBYD N/A
- EPS Growth
- STRO N/A
- FBYD N/A
- EPS
- STRO N/A
- FBYD N/A
- Revenue
- STRO $160,955,000.00
- FBYD $7,530,000.00
- Revenue This Year
- STRO N/A
- FBYD N/A
- Revenue Next Year
- STRO N/A
- FBYD N/A
- P/E Ratio
- STRO N/A
- FBYD N/A
- Revenue Growth
- STRO 230.90
- FBYD N/A
- 52 Week Low
- STRO $1.51
- FBYD $3.62
- 52 Week High
- STRO $6.13
- FBYD $13.25
- Technical
- Relative Strength Index (RSI)
- STRO 42.89
- FBYD 56.09
- Support Level
- STRO $1.76
- FBYD $6.62
- Resistance Level
- STRO $1.95
- FBYD $7.87
- Average True Range (ATR)
- STRO 0.13
- FBYD 1.23
- MACD
- STRO 0.00
- FBYD 0.22
- Stochastic Oscillator
- STRO 41.94
- FBYD 54.90
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has five operating segments, Falcon's Creative Group, PDP, Sierra Parima, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.